MedPath

MACROGENICS, INC.

MACROGENICS, INC. logo
🇺🇸United States
Ownership
Public
Established
2000-01-01
Employees
339
Market Cap
-
Website
http://www.macrogenics.com

Clinical Trials

48

Active:48
Completed:0

Trial Phases

1 Phases

Phase 1:30

Drug Approvals

2

NMPA:1
FDA:1

Drug Approvals

Margetuximab Injection

Product Name
麦甘乐
Approval Number
国药准字SJ20230009
Approval Date
Aug 29, 2023
NMPA

Clinical Trials

Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials

Phase 1
30 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.